ITMCTR2000003106尚未招募1 期
Presentation on the efficacy and safety of Kuanxiong aerosol in improving exercise tolerance in patients with coronary heart disease and angina pectoris
Guangdong Provincial Hospital of Chinese Medicine0 个研究点开始时间: 待定最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 性别
- All
入选标准
- •1. Diagnosis of coronary heart disease by coronary CT or coronary angiography;
- •2. Age 18-75 years old, no lower limb dysfunction, can complete cardiopulmonary exercise test;
- •3. Satisfy one of the following three items:
- •(1) coronary CT or coronary angiography indicates 50% -80% of coronary stenosis, but no PCI;
- •(2) PCI, coronary CT or coronary The angiography showed that other non-intervention coronary stenosis was 50% -80%, and no PCI treatment was performed.
- •(3) No obvious stenosis after PCI, but chest tightness and chest pain symptoms;
- •4. Excessive chest tightness, palpitations, chest and back pain, shortness of breath, and heart discomfort, exacerbated after the activity, and the Seattle Angina Pectoris Scale SAQ, Angina Pectoris Frequency Dimension (AF) score <= 80
- •5. Maximum oxygen uptake VO2 (l / min) maximum value / expected value% < 84%;
- •6. Subjects were informed and voluntarily signed informed consent.
排除标准
- •1. Patients with revascularization plan within 1 month;
- •2. Canadian Cardiovascular Association (CCS) patients with grade 4 stable angina;
- •3. Uncontrolled hypertension (systolic blood pressure> 180mmHg or diastolic blood pressure> 100mmHg), although patients are undergoing antihypertensive treatment;
- •4. NYHA Class IV or LVEF < 30% of patients;
- •5. Patients with coronary heart disease and atrial fibrillation;
- •6. Clinically significant comorbidities, including liver dysfunction (whose ALT or AST levels are more than 2 times higher than normal), renal impairment (serum creatinine levels are more than 2 times higher than normal), history of cerebral hemorrhage or epilepsy Patients who need anticonvulsants;
- •7. Myocardial infarction occurred 1 month before the start of the research project;
- •8. Patients with acute coronary syndrome confirmed by examination and rheumatic heart disease, dilated heart disease, severe aortic stenosis and hyperthyroidism;
- •9. Patients with hemoglobin below 90 g / L;
- •10. Intermittent claudication, or those unable to participate in cardiopulmonary function assessment due to severe leg pain;
- •11. ECG shows ST segment elevation over 2mm;
- •12. Patients participating in any other clinical research or taking their research drug within 30 days;
- •13. People with known or suspected allergies or allergies to the study drug;
- •14. Drug abusers: Patients have a recent (in the past 2 years) history of alcohol abuse or a known history of drug dependence;
- •15. Patients with malignant tumors and mental illness;
- •16. Patients who the investigator determined were not eligible to participate in the study.
研究者
相似试验
尚未招募
1 期
Evaluation of efficacy and safety of Qiangzhu-qinggan formula as an adjunctive therapy in adult patients with severe influenzainfluenzaITMCTR2000002885onghua Hospital Shanghai University of Traditional Chinese Medicine
已完成
不适用
Efficacy and safety of K-Two® versus Actico® compression system in the management of venous leg ulcers: a pilot studyISRCTN47210331aboratoires Urgo (France)232
招募中
不适用
Preliminary study on efficacy and safety of Kyung-Ok-Ko on cancer fatigue in lung cancer patients during cancer treatmentNeoplasmsKCT0003666Kyung Hee University Oriental Medical Center50
招募中
4 期
???????????????????ITMCTR2200005917Gansu Province second People's Hospital
尚未招募
1 期
Clinical study on treatment of female rheumatoid arthritis by Kunbixiao decoctioITMCTR2100004992Xiyuan Hospital, China Academy of Chinese Medical Sciences